Cargando…
Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients
BACKGROUND: Receptor activator of NFkB (RANK), its ligand (RANKL) and the decoy receptor of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating osteoclasts formation and activity. RANKL stimulates migration of RANK-expressing tumor cells in vitro, conversely inhibited b...
Autores principales: | Santini, Daniele, Schiavon, Gaia, Vincenzi, Bruno, Gaeta, Laura, Pantano, Francesco, Russo, Antonio, Ortega, Cinzia, Porta, Camillo, Galluzzo, Sara, Armento, Grazia, La Verde, Nicla, Caroti, Cinzia, Treilleux, Isabelle, Ruggiero, Alessandro, Perrone, Giuseppe, Addeo, Raffaele, Clezardin, Philippe, Muda, Andrea Onetti, Tonini, Giuseppe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084800/ https://www.ncbi.nlm.nih.gov/pubmed/21559440 http://dx.doi.org/10.1371/journal.pone.0019234 |
Ejemplares similares
-
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
por: Suriano, Francesca, et al.
Publicado: (2013) -
RANK/RANKL pathway in cancer: Biological activity beyond bone?
por: Pantano, Francesco, et al.
Publicado: (2012) -
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma
por: Vincenzi, Bruno, et al.
Publicado: (2017) -
Deregulation of dicer and mir-155 expression in liposarcoma
por: Vincenzi, Bruno, et al.
Publicado: (2015) -
In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
por: Perrone, Giuseppe, et al.
Publicado: (2012)